Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Seven-Market Drug Forecast and Market Analysis - Update (2025)" has been added to ResearchAndMarkets.com's offering.
This comprehensive report provides an in-depth analysis of the Chronic Obstructive Pulmonary Disease (COPD) market across seven major markets, featuring an Excel-based model forecasting market trends through 2033. COPD, a progressive lung disease, continues to present significant health challenges globally. Our analysis investigates this market's path over the next decade, beginning with an estimated value of $11.6 billion in 2023 and projecting growth to $30.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of 10.0%.
Our forecast encompasses both currently marketed and pipeline drugs tailored for COPD, with 2023 as the base year. Key deliverables include a detailed PDF report along with an Excel-based model providing intricate market forecasts.
Key Highlights
- Forecasting tools offered include a PDF report and an Excel-based model.
- The 7MM serves as the focal point for our projections spanning 2023 to 2033.
Scope
- Provides a detailed overview of COPD, addressing epidemiology, symptoms, diagnosis, disease management, and the Asthma-COPD Overlap (ACO).
- Includes annualized market revenue data, per patient therapy costs, and treatment usage forecasts for the period 2023-2033.
- Covers strategic competitor assessments, market dynamics, unmet needs, clinical trials, and their collective impacts on COPD therapeutics.
- Features pipeline analysis, presenting data on emerging therapeutic trends and development mechanisms, highlighting promising late-stage candidates.
- Presents a competitive analysis of the global COPD market, exploring industry drivers, barriers, and challenges.
Key Topics Covered:
- Chronic Obstructive Pulmonary Disease: Executive Summary
- Introduction
- Disease Overview
- Epidemiology
- Disease Management
- Current Treatment Options
- Unmet Needs and Opportunity Assessment
- R&D Strategies
- Pipeline Assessment
- Pipeline Valuation Analysis
- Current and Future Players
- Market Outlook
- Appendix
- About the Analyst
- Contact the Publisher
Companies Featured
- Sanofi
- Regeneron
- GSK
- AstraZeneca
- Verona Pharma
- Chiesi Pharma
- Roche
- Genentech
- Boehringer Ingelheim
- Theravance Biopharma
- Novartis
For more information about this report visit https://www.researchandmarkets.com/r/mwkggi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
